Serkan Akın

758 total citations
50 papers, 310 citations indexed

About

Serkan Akın is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Pathology and Forensic Medicine. According to data from OpenAlex, Serkan Akın has authored 50 papers receiving a total of 310 indexed citations (citations by other indexed papers that have themselves been cited), including 29 papers in Oncology, 17 papers in Pulmonary and Respiratory Medicine and 9 papers in Pathology and Forensic Medicine. Recurrent topics in Serkan Akın's work include HER2/EGFR in Cancer Research (9 papers), Breast Cancer Treatment Studies (8 papers) and Lymphoma Diagnosis and Treatment (8 papers). Serkan Akın is often cited by papers focused on HER2/EGFR in Cancer Research (9 papers), Breast Cancer Treatment Studies (8 papers) and Lymphoma Diagnosis and Treatment (8 papers). Serkan Akın collaborates with scholars based in Türkiye, United States and India. Serkan Akın's co-authors include Kadri Altundağ, Meral Tunçbilek, Rahmiye Ertan, Fikret Yılmaz, Osman Gökay, Furkan Sarici, Taner Babacan, Sercan Aksoy, Deniz Can Güven and Taha Koray Şahin and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Annals of Oncology.

In The Last Decade

Serkan Akın

41 papers receiving 299 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Serkan Akın Türkiye	9	133	69	61	50	47	50	310
Roger Tell Sweden	10	166 1.2×	28 0.4×	60 1.0×	14 0.3×	24 0.5×	22	390
Takayoshi Oikawa Japan	12	50 0.4×	22 0.3×	45 0.7×	22 0.4×	24 0.5×	35	345
Shui‐Sang Hsue Taiwan	12	94 0.7×	33 0.5×	39 0.6×	196 3.9×	31 0.7×	18	410
T Igarashi Japan	10	148 1.1×	7 0.1×	80 1.3×	70 1.4×	86 1.8×	26	436
Yasser Khaled United States	8	126 0.9×	16 0.2×	8 0.1×	14 0.3×	4 0.1×	27	385
J.A. Marks United States	3	149 1.1×	4 0.1×	208 3.4×	27 0.5×	42 0.9×	5	576
Nevena Sečen Serbia	8	443 3.3×	5 0.1×	224 3.7×	4 0.1×	41 0.9×	18	656
Yasuyuki Michi Japan	13	108 0.8×	2 0.0×	44 0.7×	135 2.7×	45 1.0×	72	428
Elizabeth Robles Mexico	8	65 0.5×	8 0.1×	40 0.7×	3 0.1×	21 0.4×	13	336
Jed Abraham Katzel United States	7	108 0.8×		50 0.8×	37 0.7×	32 0.7×	16	324

Countries citing papers authored by Serkan Akın

Since Specialization

Citations

This map shows the geographic impact of Serkan Akın's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Serkan Akın with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Serkan Akın more than expected).

Fields of papers citing papers by Serkan Akın

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Serkan Akın. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Serkan Akın. The network helps show where Serkan Akın may publish in the future.

Co-authorship network of co-authors of Serkan Akın

This figure shows the co-authorship network connecting the top 25 collaborators of Serkan Akın. A scholar is included among the top collaborators of Serkan Akın based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Serkan Akın. Serkan Akın is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Şahin, Taha Koray, et al.. (2025). Impact of Time-to-Treatment Initiation and First Inter-Cycle Delay in Patients with Hodgkin Lymphoma. Journal of Clinical Medicine. 14(12). 4085–4085.

Güven, Deniz Can, Necla Özer, Yusuf Ziya Şener, et al.. (2025). Serum Albumin–Creatinine Ratio and Anthracycline Cardiotoxicity in Patients with Cancer. Journal of Clinical Medicine. 14(5). 1741–1741. 2 indexed citations

Güven, Deniz Can, et al.. (2024). Factors Influencing Immunotherapy Outcomes in Cancer: Sarcopenia and Systemic Inflammation. Cancer Control. 31. 2925720296–2925720296. 4 indexed citations

Özçakar, Levent, Mehmet Ruhi Onur, Oktay Halit Aktepe, et al.. (2024). Sonographic Measurements of Rectus Femoris Muscle Thickness Strongly Predict Neutropenia in Cancer Patients Receiving Chemotherapy. Cancers. 16(5). 1061–1061. 1 indexed citations

Yazıcı, Gözde, et al.. (2024). The Role of Radiotherapy in Indolent Ocular Adnexal and Orbital Lymphomas. Head & Neck. 47(3). 891–898.

Koç, İrem, et al.. (2023). Comprehensive analysis of orbital lymphoma in a Turkish cohort: clinical characteristics, histological subtypes, treatment modalities, prognostic factors, and implications for management. Annals of Hematology. 103(3). 905–915.

Güven, Deniz Can, Taha Koray Şahin, Serkan Akın, & Fatih M. Uckun. (2022). Impact of Therapy in Patients with Hematologic Malignancies on Seroconversion Rates After SARS-CoV-2 Vaccination. The Oncologist. 27(4). e357–e361. 13 indexed citations

Güven, Deniz Can, Taha Koray Şahin, Serkan Akın, & Fatih M. Uckun. (2022). SARS-CoV-2 Vaccine Efficacy in Patients with Hematologic Malignancies: Practical Points for Further Research. The Oncologist. 27(11). e917–e918.

Srour, Samer A. & Serkan Akın. (2022). Chimeric Antigen Receptor T-Cell Therapy for Solid Tumors: The Past and the Future. SHILAP Revista de lepidopterología. 6(1). 19–30. 12 indexed citations

10.

Akın, Serkan, et al.. (2021). <sup>18</sup>F-FDG PET/CT Imaging of Metastatic Testicular Choriocarcinoma Mimicking Gastric Cancer which Initial Symptom is Melena. Molecular Imaging and Radionuclide Therapy. 30(1). 47–49. 1 indexed citations

11.

Akın, Serkan, et al.. (2018). Ifosfamide and doxorubicin in the treatment of advanced leiomyosarcoma. Current Problems in Cancer. 42(3). 344–349. 8 indexed citations

12.

Sarici, Furkan, Taner Babacan, Hakan Büyükhatipoğlu, et al.. (2017). Correlation of educational status and clinicopathological characteristics of breast cancer: a single center experience.. PubMed. 21(4). 826–831.

13.

Gündüz, Mehmet, Öztürk Ateş, Taner Babacan, et al.. (2017). Trastuzumab 1-year vs 9-week in early-stage HER2-positive, lymph node negative breast cancer patients.. PubMed. 21(4). 799–808.

14.

Ateş, Öztürk, Taner Babacan, Neyran Kertmen, et al.. (2016). Efficacy and safety of eribulin monotherapy in patients with heavily pretreated metastatic breast cancer.. PubMed. 21(2). 375–81. 7 indexed citations

15.

Akın, Serkan, et al.. (2016). Vaccination perception and attitudes among patients with cancer receiving chemotherapy. Annals of Oncology. 27. vi514–vi514. 2 indexed citations

16.

Kertmen, Neyran, Taner Babacan, Özge Keskin, et al.. (2015). Molecular subtypes in patients with inflammatory breast cancer; a single center experience.. PubMed. 20(1). 35–9. 16 indexed citations

17.

Babacan, Taner, Hakan Büyükhatipoğlu, Neyran Kertmen, et al.. (2015). Chemotherapy might not be beneficial in lymph node- negative, hormone-positive, and HER2-negative breast cancer patients: a long-term retrospective analysis.. PubMed. 20(2). 479–86. 2 indexed citations

18.

Kertmen, Neyran, Sercan Aksoy, Mustafa Cengiz, et al.. (2015). Comparison of Three Different Induction Regimens for Nasopharyngeal Cancer. Asian Pacific Journal of Cancer Prevention. 16(1). 59–63. 2 indexed citations

19.

Babacan, Taner, Orhan Efe, Hakan Büyükhatipoğlu, et al.. (2015). Efficacy of Capecitabine Monotherapy as the First-line Treatment of Metastatic HER2-negative Breast Cancer. Tumori Journal. 101(4). 418–423. 8 indexed citations

20.

Gökay, Osman, Fikret Yılmaz, Serkan Akın, Meral Tunçbilek, & Rahmiye Ertan. (2000). Penetration of the Pulp Chamber by Bleaching Agents in Teeth Restored with Various Restorative Materials. Journal of Endodontics. 26(2). 92–94. 70 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact